NCT06024538View on ClinicalTrials.gov

Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies

Not yet recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Lung NeoplasmCancer Associated FibroblastMyeloid-Derived Suppressive Cells Immunosuppression
Interventions
PROCEDURE

Tumor samples

Tumor samples will be collected by the pathologist at the reception of the tumor removed during surgery

Trial Locations (1)

33000

CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médicale, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER